4-Hydrazinobenzoic Acid Hydrochloride CAS 24589-77-3 Purity >98.0% (HPLC)

Short Description:

Name: 4-Hydrazinobenzoic Acid Hydrochloride 

CAS: 24589-77-3

Purity: >98.0% (HPLC) 

Appearance: Off-White to Yellow Powder

Intermediate of Deferasirox (CAS: 201530-41-8)

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4-Hydrazinobenzoic Acid Hydrochloride (CAS: 24589-77-3) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name 4-Hydrazinobenzoic Acid Hydrochloride 
Synonyms 4-Hydrazinobenzoic Acid HCl; p-Hydrazinobenzoic Acid Hydrochloride; p-Carboxyphenylhydrazine Hydrochloride; 4-Carboxyphenylhydrazine Hydrochloride 
CAS Number 24589-77-3 
CAT Number RF2739
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C7H8NO2·HCl 
Molecular Weight 188.61 
Melting Point 250.0~253.0℃(lit.) 
Sensitivity & Storage  Hygroscopic. Ambient Temperatures.
Water Solubility Soluble in Water
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance Off-White to Yellow Powder
Purity / Analysis Method >98.0% (HPLC) 
Purity (Titration by AgNO3) 97.5~102.5%
Melting Point 250.0~253.0℃
Water (by Karl Fischer) <1.00%
Total Impurities <2.00%
Infrared Spectrum Conforms to Structure
Proton NMR Spectrum Conforms to Structure
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates; Deferasirox Intermediate

Package & Storage:

Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

FAQ:

How to Purchase? Please contact: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Russia, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

Application:

4-Hydrazinobenzoic Acid Hydrochloride (CAS: 24589-77-3) is an important raw material and intermediate used in organic synthesis, pharmaceuticals. 4-Hydrazinobenzoic Acid Hydrochloride is an intermediate of Deferasirox (CAS: 201530-41-8). Deferasirox is a kind of iron chelator products studied and developed by the Novartis company (Swiss). It was the first routinely used oral iron agent approved by US FDA, allowed to be applied for the treatment of iron overloading caused by blood transfusion in patients (older than 2 years old) of chronic anemia. In Europe, it is recommended as the first-line treatment drug for patients older than 6-year-old who are suffering blood iron overload patients. 

  • Write your message here and send it to us